Sygnature Discovery > Drug Discovery > Bioscience > Biomarker Discovery

Biomarker Discovery

A high quality, sensitive biomarker can provide vital information to project teams throughout the discovery and development pipeline, information which can be used to instruct project progression strategies into the clinic.

Biomarker Discovery Identification

Sygnature’s collaborative and flexible approach to biomarker identification and validation ensures the development of an appropriate and robust biomarker that is fit for purpose.

We have developed a wealth of expertise in the identification and validation of pharmacodynamic (PD) biomarker such as genes, phosphoproteins and cytokines.

Our scientists offer biomarker identification and assay development expertise across a range of therapeutic areas.

 

 

Biomarker Discovery Services

Tumour Biopsy Analysis

Our experienced scientists here at Sygnature Discovery can help you develop appropriate exploratory Biomarkers to support pre-clinical and Mechanism of Action studies within your Therapeutic Indication.

DISCOVER

Gene Expression

Sygnature Discovery provides a wide array of capabilities to support gene expression studies, providing analysis of both single gene changes, as well as, analysis of the expression levels of the entire transcriptome.

DISCOVER

Phosphoproteins and Cytokines

At Sygnature Discovery, we have developed a wealth of expertise in the identification and validation of pharmacodynamic (PD) biomarkers including phosphoproteins which can be applied to all phases of the drug discovery process from early preclinical studies through to the clinic.

DISCOVER